Patents by Inventor Fuller W. Bazer

Fuller W. Bazer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of lactogenic and somatogenic hormones to enhance reproductive efficiency in mammals
    Publication number: 20030109441
    Abstract: The present invention is generally directed to improving fertility in mammals. Methods of the present invention include increasing reproductive efficiency in mammals by administering at least one lactogenic or somatogenic hormone to a mammal in order to increase reproductive efficiency. Additional methods of the present invention include increasing endometrial adenogenesis in a mammal.
    Type: Application
    Filed: September 18, 2002
    Publication date: June 12, 2003
    Applicant: Texas A&M University
    Inventors: Thomas E. Spencer, Fuller W. Bazer
  • METHODS COMPRISING APOPTOSIS INHIBITORS FOR THE GENERATION OF TRANSGENIC PIGS
    Publication number: 20020045253
    Abstract: Disclosed are methods for the isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines, and using these transformed cells and cell lines to generate transgenic animals. The efficiency at which transgenic animals are generated by the present invention is greatly increased, thereby allowing the use of homologous recombination in producing transgenic non-rodent animal species.
    Type: Application
    Filed: March 28, 2001
    Publication date: April 18, 2002
    Applicant: The Texas A & M University System
    Inventors: Jorge A. Piedrahita, Fuller W. Bazer
  • Methods comprising apoptosis inhibitors for the generation of transgenic pigs
    Patent number: 6369294
    Abstract: Disclosed are methods for the isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines, and using these transformed cells and cell lines to generate transgenic animals. The efficiency at which transgenic animals are generated by the present invention is greatly increased, thereby allowing the use of homologous recombination in producing transgenic non-rodent animal species.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: April 9, 2002
    Assignee: Texas A&M University System
    Inventors: Jorge A. Piedrahita, Fuller W. Bazer
  • Cells and methods for the generation of transgenic pigs
    Patent number: 6271436
    Abstract: Disclosed are methods for the isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines, and using these transformed cells and cell lines to generate transgenic animals. The efficiency at which transgenic animals are generated by the present invention is greatly increased, thereby allowing the use of homologous recombination in producing transgenic non-rodent animal species.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: August 7, 2001
    Assignee: The Texas A & M University System
    Inventors: Jorge A. Piedrahita, Fuller W. Bazer
  • Uteroferrin and rose proteins for stimulating hematopoietic cells
    Patent number: 5258367
    Abstract: Method of using uteroferrin and rose for stimulating proliferation of hematopoietic cells.
    Type: Grant
    Filed: June 29, 1990
    Date of Patent: November 2, 1993
    Assignee: University of Florida
    Inventors: Fuller W. Bazer, Samuel Gross
  • Use of supplemental dietary riboflavin to increase fertility and/or prolificacy in animals
    Patent number: 5063226
    Abstract: A novel method for enhancing the fertility and/or prolificacy of non-ruminant animals is provided. Riboflavin is administered in enhanced levels during gestation and, particularly, during a critical phase of gestation. The beneficial effects are achieved by elevating the concentration of riboflavin in the uterine fluids which surround the developing embryo.
    Type: Grant
    Filed: March 29, 1990
    Date of Patent: November 5, 1991
    Assignee: University of Florida
    Inventor: Fuller W. Bazer